{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:08:59Z","timestamp":1781910539367,"version":"3.54.5"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T00:00:00Z","timestamp":1777248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum des Saarlandes und Medizinische Fakult\u00e4t der Universit\u00e4t des Saarlandes"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol. Res. Pract."],"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>INSPIRE-PNRM+ (short for InterdiSciPlinary and InteRsectoral telemedIcal Evaluation, Coordination and Therapy at the ParkinsonNet RheinMain+) is an one-year, multicentre, interventional, open-label, two-arm, 1:1 randomized controlled trial (RCT) with the goal to improve the quality of care for Parkinson\u2019s disease (PD) patients outside of a specialized clinical context. The study is funded by the German Innovation Fund mandated by the Federal Joint Committee (G-BA). The three core characteristics are (1) the employment of specially trained advanced practice nurses (APN) in an (2) interdisciplinary network and (3) the use of a specifically designed digital platform. This platform serves for documentation and communication, thereby helping patients receive individualized, guideline-based treatment and support in adapting their lives to the effects of the disease. 844 patients will be recruited. They will be divided into two groups: a \u201cusual care\u201d group which continues traditional care (i.e., usually consultation with a neurologist in private practice) vs. the \u201cintervention\u201d group which will have APN contact every three months or more frequently as needed over the period of 12 months. Patients\u2019 quality of life serves as primary outcome measure, combined with a process evaluation and health economic analysis (cost-utility analysis (CUA)). Recruitment was ongoing at time of submission of this paper. This innovative study is the first in Germany where APNs are dedicated to PD care. The study may serve as blueprint when incorporating APNs into routine healthcare, similar to other countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      The study has been registered at\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"http:\/\/www.clinicaltrials.gov\" ext-link-type=\"uri\">www.clinicaltrials.gov<\/jats:ext-link>\n                      , NCT06479083. Registered June 27, 2024.\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/clinicaltrials.gov\/study\/NCT06479083?term=INSPIRE%20Parkinson%26rank=1\" ext-link-type=\"uri\">https:\/\/clinicaltrials.gov\/study\/NCT06479083?term=INSPIRE%20Parkinson&amp;rank=1<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s42466-026-00476-6","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:42:11Z","timestamp":1777293731000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Protocol of the interdisciplinary and intersectoral randomized controlled trial in Parkinson patients in a specialized network in Germany: the INSPIRE Trial"],"prefix":"10.1186","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7283-1995","authenticated-orcid":false,"given":"Susanne A.","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Paryjas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Philipp","family":"Bach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Baudrexel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Baier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moaz Al","family":"Ajia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona","family":"Csoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Gehring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Gonzalez","family":"Escamilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian M.","family":"Herz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Leisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonore","family":"K\u00f6hler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea-Marie","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Martens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"Meier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Scheipers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Schiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nils","family":"Schr\u00f6ter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieke","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Specht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Erbsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Stemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiu","family":"Groppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,27]]},"reference":[{"key":"476_CR1","first-page":"e13070","volume":"10","author":"A Rommel","year":"2025","unstructured":"Rommel, A., Deuschl, G., Dodel, R., et al. (2025). Parkinson disease - Prevalence, trends and regional patterns in Germany. An analysis based on routine data from the statutory health insurance. J Health Monit, 10, e13070.","journal-title":"J Health Monit"},{"key":"476_CR2","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","volume":"397","author":"BR Bloem","year":"2021","unstructured":"Bloem, B. R., Okun, M. S., & Klein, C. (2021). Parkinson\u2019s disease. Lancet, 397, 2284\u20132303.","journal-title":"Lancet"},{"key":"476_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/ene.13412","volume":"25","author":"AB Deutschlander","year":"2018","unstructured":"Deutschlander, A. B., Ross, O. A., Dickson, D. W., & Wszolek, Z. K. (2018). Atypical parkinsonian syndromes: A general neurologist\u2019s perspective. European Journal of Neurology, 25, 41\u201358.","journal-title":"European Journal of Neurology"},{"key":"476_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s42466-024-00325-4","volume":"6","author":"G Hoglinger","year":"2024","unstructured":"Hoglinger, G., German Parkinson\u2019s Guidelines, C., & Trenkwalder, C. (2024). Diagnosis and treatment of Parkinson s disease (guideline of the German Society for Neurology). Neurol Res Pract, 6, 30.","journal-title":"Neurol Res Pract"},{"key":"476_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s42466-025-00383-2","volume":"7","author":"M Sudmeyer","year":"2025","unstructured":"Sudmeyer, M., Pedrosa, D. J., Siebecker, F., Arlt, C., Kopra, J., & Jost, W. H. (2025). Real-world disease burden and planned treatment optimization after MANAGE-PD implementation in Germany: A cross-sectional study. Neurology Research and Practice, 7, Article 31.","journal-title":"Neurology Research and Practice"},{"key":"476_CR6","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","volume":"68","author":"ER Dorsey","year":"2007","unstructured":"Dorsey, E. R., Constantinescu, R., Thompson, J. P., et al. (2007). Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology, 68, 384\u2013386.","journal-title":"Neurology"},{"key":"476_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080952","volume":"388","author":"D Su","year":"2025","unstructured":"Su, D., Cui, Y., He, C., et al. (2025). Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: Modelling study of Global Burden of Disease Study 2021. BMJ, 388, Article e080952.","journal-title":"BMJ"},{"key":"476_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s42466-023-00300-5","volume":"6","author":"C Lummer","year":"2024","unstructured":"Lummer, C., Eggers, C., Becker, A., Demandt, F., & Warnecke, T. (2024). Parkinson Netzwerke Deutschland e V. Interdisciplinary network care collaboration in Parkinson\u2019s disease: A baseline evaluation in Germany. Neurol Res Pract, 6, 5.","journal-title":"Neurol Res Pract"},{"key":"476_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/geriatrics7020046","author":"E Tenison","year":"2022","unstructured":"Tenison, E., James, A., Ebenezer, L., & Henderson, E. J. (2022). A narrative review of specialist Parkinson\u2019s nurses: Evolution, evidence and expectation. Geriatrics. https:\/\/doi.org\/10.3390\/geriatrics7020046","journal-title":"Geriatrics"},{"key":"476_CR10","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1155\/1994\/916963","volume":"7","author":"M Jahanshahi","year":"1994","unstructured":"Jahanshahi, M., Brown, R. G., Whitehouse, C., Quinn, N., & Marsden, C. D. (1994). Contact with a nurse practitioner: A short-term evaluation study in Parkinson\u2019s disease and dystonia. Behavioral Neurology, 7, 189\u2013196.","journal-title":"Behavioral Neurology"},{"key":"476_CR11","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1136\/bmj.324.7345.1072","volume":"324","author":"B Jarman","year":"2002","unstructured":"Jarman, B., Hurwitz, B., Cook, A., Bajekal, M., & Lee, A. (2002). Effects of community based nurses specialising in Parkinson\u2019s disease on health outcome and costs: Randomised controlled trial. BMJ, 324, 1072\u20131075.","journal-title":"BMJ"},{"key":"476_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/j.1365-2753.2005.00495.x","volume":"11","author":"B Hurwitz","year":"2005","unstructured":"Hurwitz, B., Jarman, B., Cook, A., & Bajekal, M. (2005). Scientific evaluation of community-based Parkinson\u2019s disease nurse specialists on patient outcomes and health care costs. Journal of Evaluation in Clinical Practice, 11, 97\u2013110.","journal-title":"Journal of Evaluation in Clinical Practice"},{"key":"476_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11070623","author":"M van Munster","year":"2021","unstructured":"van Munster, M., Stumpel, J., Thieken, F., et al. (2021). Moving towards integrated and personalized care in Parkinson\u2019s disease: A framework proposal for training Parkinson nurses. Journal of Personalized Medicine. https:\/\/doi.org\/10.3390\/jpm11070623","journal-title":"Journal of Personalized Medicine"},{"key":"476_CR14","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1007\/s00415-018-8761-7","volume":"265","author":"C Eggers","year":"2018","unstructured":"Eggers, C., Dano, R., Schill, J., et al. (2018). Patient-centered integrated healthcare improves quality of life in Parkinson\u2019s disease patients: A randomized controlled trial. Journal of Neurology, 265, 764\u2013773.","journal-title":"Journal of Neurology"},{"key":"476_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3926-y","volume":"21","author":"DLM Radder","year":"2020","unstructured":"Radder, D. L. M., Lennaerts, H. H., Vermeulen, H., et al. (2020). The cost-effectiveness of specialized nursing interventions for people with Parkinson\u2019s disease: The NICE-PD study protocol for a randomized controlled clinical trial. Trials, 21, Article 88.","journal-title":"Trials"},{"key":"476_CR16","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1002\/mds.25194","volume":"28","author":"MA van der Marck","year":"2013","unstructured":"van der Marck, M. A., Bloem, B. R., Borm, G. F., Overeem, S., Munneke, M., & Guttman, M. (2013). Effectiveness of multidisciplinary care for Parkinson\u2019s disease: A randomized, controlled trial. Movement Disorders, 28, 605\u2013611.","journal-title":"Movement Disorders"},{"key":"476_CR17","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.3233\/JPD-202078","volume":"10","author":"DLM Radder","year":"2020","unstructured":"Radder, D. L. M., Nonnekes, J., van Nimwegen, M., et al. (2020). Recommendations for the organization of multidisciplinary clinical care teams in Parkinson\u2019s Disease. Journal of Parkinson\u2019s Disease, 10, 1087\u20131098.","journal-title":"Journal of Parkinson's Disease"}],"container-title":["Neurological Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-026-00476-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42466-026-00476-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42466-026-00476-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:48:32Z","timestamp":1781650112000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s42466-026-00476-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,27]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["476"],"URL":"https:\/\/doi.org\/10.1186\/s42466-026-00476-6","relation":{},"ISSN":["2524-3489"],"issn-type":[{"value":"2524-3489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,27]]},"assertion":[{"value":"16 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"See Section \u201cStudy oversight and Ethics\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"IC was consultant and\/or speaker for Danone, Neuraxpharm, Zambon GmbH, Abbvie GmbH, Desitin and Bial GmbH, and she received travel compensation from Abbvie. The remaining authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}